Overview

Evaluation Of Efficacy And Safety Of Norspan In Moderate To Severe Pain Due To Osteoarthritis, Rheumatoid Arthritis, Joint/Muscle Pain

Status:
Completed

Trial end date:
2015-01-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess the efficacy of the buprenorphine transdermal patch (Norspan® or Sovenor® transdermal patch) in patients with chronic non-malignant pain of moderate to severe intensity due to osteoarthritis, rheumatoid arthritis, lower back pain and joint/muscle pain, who are not adequately responding to non-opioid painkillers.

Phase:

Phase 4

Details

Lead Sponsor:

Mundipharma Pte Ltd.

Collaborators:

Mundipharma (Hong Kong) Ltd
Mundipharma Distribution GmBH (Philippine Branch)
Mundipharma Korea Ltd

Treatments:

Buprenorphine